TA
BPMC

Teachers Advisors’s Blueprint Medicines BPMC Stock Holding History

Teachers Advisors’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$7.33M Sell
91,584
-92,464
-50% -$6.83M 0.01% 1175
2018
Q4 		$9.92M Buy
184,048
+1,251
+0.7% +$76K 0.01% 937
2018
Q3 		$14.3M Buy
182,797
+4,600
+3% +$320K 0.02% 895
2018
Q2 		$11.3M Buy
178,197
+1,758
+1% +$140K 0.01% 1029
2018
Q1 		$16.2M Sell
176,439
-67,398
-28% -$5.81M 0.02% 812
2017
Q4 		$18.4M Buy
243,837
+4,754
+2% +$334K 0.02% 759
2017
Q3 		$16.7M Sell
239,083
-490
-0.2% -$26.2K 0.02% 774
2017
Q2 		$12.1M Buy
239,573
+198,251
+480% +$8.42M 0.02% 906
2017
Q1 		$1.65M Buy
41,322
+8,390
+25% +$300K ﹤0.01% 1873
2016
Q4 		$924K Buy
32,932
+881
+3% +$26.6K ﹤0.01% 2223
2016
Q3 		$952K Hold
32,051
– – ﹤0.01% 2094
2016
Q2 		$649K Buy
32,051
+18,413
+135% +$335K ﹤0.01% 2274
2016
Q1 		$246K Hold
13,638
– – ﹤0.01% 2712
2015
Q4 		$359K Hold
13,638
– – ﹤0.01% 2599
2015
Q3 		$291K Hold
13,638
– – ﹤0.01% 2704
2015
Q2 		$361K Buy
+13,638
New +$389K ﹤0.01% 2723

Other funds holding BPMC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Teachers Advisors's BPMC Position: Q1 2019 in Review

Teachers Advisors reduced its Blueprint Medicines (BPMC) stake by 50% in Q1 2019, selling an estimated $6.83M and leaving 91,584 shares worth $7.33M. The position accounts for 0.01% of the portfolio, ranked #1175.

Teachers Advisors first reported a position in BPMC in Q2 2015 and has held it in 16 quarters since. The position peaked at $18.4M in Q4 2017. 203 funds tracked by Wall St. Rank hold BPMC as of Q1 2019.

  • Teachers Advisors held 91,584 shares of Blueprint Medicines worth $7.33M as of Q1 2019.
  • Teachers Advisors sold 92,464 Blueprint Medicines shares in Q1 2019, an estimated $6.83M.
  • Blueprint Medicines made up 0.01% of Teachers Advisors's portfolio in Q1 2019, its #1175 holding.
  • Teachers Advisors first reported a position in Blueprint Medicines in Q2 2015 and has held it in 16 quarters since.
  • Teachers Advisors's Blueprint Medicines position peaked at $18.4M in Q4 2017.
  • 203 funds tracked by Wall St. Rank held Blueprint Medicines as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.